Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Treatment of paediatric keratoconus: short-term results and management algorithm

Poster Details

First Author: E. Jarade LEBANON

Co Author(s):    S. El-Khoury   E. Chelala   Y. Abdelmassih   M. Amro           

Abstract Details

Purpose:

To report the safety and early outcome of a new treatment algorithm for pediatric keratoconus in a tertiary referral eye hospital in Beirut, Lebanon.

Setting:

Tertiary refferal center at Beirut Eye Specialist Hospital

Methods:

Pediatric (9 to 14 years old) keratoconus (PKC) patients were treated according to a new treatment algorithm. All PKC patients were subjected to crosslinking (CXL) treatment. Intracorneal ring segment (ICRS) implantation was indicated either to improve BCVA and/or to decrease the magnitude of anisometropia and was performed one month before CXL. Phakic intraocular lens (IOL) was indicated in case of severe anisometropia, but acceptable best-corrected visual acuity (BCVA). Perforating keratoplasty (PKP) should be kept as a last resort treatment

Results:

26 eyes of 14 patients were included. 9 eyes with good BCVA (0.07±0.04logMAR) received only CXL. 16 eyes with poor BCVA received ICRS-CXL. One eye with high residual anisometropia after ICRS-CXL received phakic IOL insertion. One eye needed a PKP. UCVA, BCVA and K-readings were not affected by the CXL treatment alone; refractive values showed minor improvements [sphere: -2.03±1.94D to -1.64±1.90 (p=0.03); cylinder: 2.22±2.10D to 1.78±2.06 (p=0.06)]. In the ICRS-CXL treatment group significant improvement was noted in BCVA [0.42±0.43logMAR to 0.15±0.14logMAR (p=0.004)], sphere [-6.13±4.28D to -3.86±5.07 (p=0.003)], cylinder [3.46±1.42D to 2.41±1.56 (p=0.034)] and Kmax [55.6±10.57D to 50.7±5.66 (p=0.009)]. All procedures were well tolerated with no keratoconus progression

Conclusions:

Though there is no clear guideline for PKC treatment, our early results show that the algorithm put forth may consist of a useful guideline for the treatment of PKC. A longer follow-up period is mandatory

Financial Disclosure:

NONE

Back to Poster listing